Disclosed is the use of an isolated peptide consisting of no more than 15 amino acids and comprising an amino acid sequence of WEHVNAIQEARRLL, i.e., SEQ ID NO: 114, in the manufacture of a pharmaceutical composition for use in a method for preventing, treating, ameliorating or managing cancer or a neoplastic disorder.